SGMT fundamentals
An in-depth look to Sagimet Biosciences Inc. - Series A operating, investing, and financing activities
SGMT free cash flow for Q2 24 is -5.63 M USD. For 2023, SGMT free cash flow was -23.77 M USD and operating cash flow was -23.77 M USD.
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM